IPO Issue Details
Issue Price / Price Band₹45 per share (Fixed Price)
Face Value₹1 Per Share
Lot Size333 Shares per Lot
Total Issue Size3,08,59,704 shares (agg. up to ₹139 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryOFS only
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenFri, 05 Jun 2026
Subscription CloseTue, 09 Jun 2026
Anchor AllotmentThu, 04 Jun 2026
Basis of AllotmentWed, 10 Jun 2026
Initiation of RefundsThu, 11 Jun 2026
Credit of Shares to DematThu, 11 Jun 2026
Listing DateFri, 12 Jun 2026
UPI Mandate Deadline5:00 PM on 09 Jun 2026 (Day 3)
Application & Investment Details
Retail — Min (1 Lots)₹14,985 — 333 shares
Retail — Max (13 Lots)₹194,805 (13 Lots)
HNI — Min (3 Lots)₹44,955 — 999 shares
EPS (Pre-IPO)₹1.98
EPS (Post-IPO)₹2.93
P/E Ratio (Pre-IPO)22.69x
P/E Ratio (Post-IPO)15.35x
Pre-IPO Promoter Holding12,29,18,109 shares
Post-IPO Promoter Holding12,29,18,109 shares
Offer for Sale Shares3,08,59,704 shares of ₹1 (agg. up to ₹139 Cr)
About Hexagon Nutrition Ltd
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.Its product portfolio is classified into three segments:Branded wellness and clinical nutrition products (B2C)Premix formulations (B2B2C)Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiativesHexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence.The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Objects of the Issue
(Standard — DRHP pending)
Hexagon Nutrition Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Funding of Capital Expenditure Requirements
2
Working Capital Requirements
3
General Corporate Purposes
Detailed fund allocation will be available once the company files DRHP with
SEBI.
Shareholding & Lock-in
Pre-IPO Promoter Holding
12,29,18,109 shares
Post-IPO Promoter Holding
12,29,18,109 shares
Lock-in Period (30%)Fri, Jul 10, 2026
Lock-in Period (50%)Tue, Sep 8, 2026